Publication:
An EAACI task force report: recognising the potential of the primary care physician in the diagnosis and management of drug hypersensitivity.

dc.contributor.authorDoña, I
dc.contributor.authorCaubet, J C
dc.contributor.authorBrockow, K
dc.contributor.authorDoyle, M
dc.contributor.authorMoreno, E
dc.contributor.authorTerreehorst, I
dc.contributor.authorTorres, M J
dc.contributor.funderInstitute of Health “Carlos III” of the Ministry of Economy and Competitiveness
dc.contributor.funderEuropean Regional Development Fund (ERDF)
dc.contributor.funderRIRAAF
dc.contributor.funderARADyAL
dc.date.accessioned2023-01-25T10:08:53Z
dc.date.available2023-01-25T10:08:53Z
dc.date.issued2018-05-10
dc.description.abstractAdverse drug reactions include drug hypersensitivity reactions (DHRs), which can be immunologically mediated (allergy) or non-immunologically mediated. The high number of DHRs that are unconfirmed and often self-reported is a frequent problem in daily clinical practice, with considerable impact on future prescription choices and patient health. It is important to distinguish between hypersensitivity and non-hypersensitivity reactions by adopting a structured diagnostic approach to confirm or discard the suspected drug, not only to avoid life-threatening reactions, but also to reduce the frequent over-diagnosis of DHRs. Primary care physicians are often the first point of contact for the sufferer of a reaction, as such they have a key role in deciding whether to discard the diagnosis or send the patient for further investigation. In this review, we highlight the importance of diagnosing DHRs, analysing in detail the role of primary care physicians. We describe the common patterns of DHRs and signs of its progression, as well as the indications and contraindications for referring the patient to an allergist. The diagnostic process is described and the possible tests are discussed, which often depend on the drug involved and the type of DHR suspected. We also describe recommendations regarding the avoidance of medication suspected to have caused the reaction and the use of alternatives.
dc.description.sponsorshipThe present study has been supported in part by Institute of Health “Carlos III” of the Ministry of Economy and Competitiveness [Grants cofunded by European Regional Development Fund (ERDF): PI15/01206, RIRAAF RD12/0013/0001 and ARADyAL RD16/0006/0001]. I Doña holds a Juan Rodes research contract (JR15/00036) from the Carlos III National Health Institute, Spanish Ministry of Economy and Competitiveness (Grants cofounded by European Social Fund, ESF).
dc.description.versionSi
dc.identifier.citationDoña I, Caubet JC, Brockow K, Doyle M, Moreno E, Terreehorst I, et al. An EAACI task force report: recognising the potential of the primary care physician in the diagnosis and management of drug hypersensitivity. Clin Transl Allergy. 2018 May 10;8:16
dc.identifier.doi10.1186/s13601-018-0202-2
dc.identifier.issn2045-7022
dc.identifier.pmcPMC5944153
dc.identifier.pmid29760877
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944153/pdf
dc.identifier.unpaywallURLhttps://doi.org/10.1186/s13601-018-0202-2
dc.identifier.urihttp://hdl.handle.net/10668/12466
dc.journal.titleClinical and translational allergy
dc.journal.titleabbreviationClin Transl Allergy
dc.language.isoen
dc.organizationHospital Universitario Regional de Málaga
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.page.number12
dc.provenanceRealizada la curación de contenido 20/02/2025
dc.publisherBioMed Central
dc.pubmedtypeJournal Article
dc.pubmedtypeReview
dc.relation.projectIDPI15/01206
dc.relation.projectIDRD12/0013/0001
dc.relation.projectIDRD16/0006/0001
dc.relation.projectIDJR15/00036
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAnaphylaxis
dc.subjectBetalactam
dc.subjectDrug allergy
dc.subjectDrug provocation test
dc.subjectExanthem
dc.subject.decsHipersensibilidad
dc.subject.decsMédicos de atención primaria
dc.subject.decsHipersensibilidad a las drogas
dc.subject.decsAlergólogos
dc.subject.decsPrescripciones
dc.subject.meshHypersensitivity
dc.subject.meshNon-steroidal anti-inflammatory drugs
dc.subject.meshSkin test
dc.subject.meshUrticaria
dc.titleAn EAACI task force report: recognising the potential of the primary care physician in the diagnosis and management of drug hypersensitivity.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number8
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC5944153.pdf
Size:
1.15 MB
Format:
Adobe Portable Document Format